肠道破坏者：白细胞介素-17不惧白细胞介素-23。
Gut-Busters: IL-17 Ain't Afraid of No IL-23.
作者信息
Whibley Natasha, Gaffen Sarah L
机构信息
Kennedy Institute of Rheumatology, University of Oxford, Oxford, OX3 7FY, UK.
Division of Rheumatology & Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh PA 15261, USA.
出版信息
Immunity. 2015 Oct 20;43(4):620-2. doi: 10.1016/j.immuni.2015.10.001.
Abstract
Interleukin-23 (IL-23) is considered a critical regulator of IL-17 in lymphocytes. Whereas antibodies targeting IL-23 ameliorate colitis, IL-17 neutralization exacerbates disease. In this issue, Cua and colleagues and Maxwell and colleagues show that IL-17 maintains intestinal barrier integrity, helping explain this dichotomy (Lee et al., 2015; Maxwell et al., 2015).
摘要
白细胞介素-23（IL-23）被认为是淋巴细胞中IL-17的关键调节因子。尽管靶向IL-23的抗体可改善结肠炎，但中和IL-17却会加重疾病。在本期杂志中，库阿及其同事以及麦克斯韦及其同事表明，IL-17可维持肠道屏障的完整性，这有助于解释这种矛盾现象（李等人，2015年；麦克斯韦等人，2015年）。
相似文献
1
Gut-Busters: IL-17 Ain't Afraid of No IL-23.肠道破坏者：白细胞介素-17不惧白细胞介素-23。
Immunity. 2015 Oct 20;43(4):620-2. doi: 10.1016/j.immuni.2015.10.001.
2
Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation.白细胞介素-23 和白细胞介素-17 在肠道免疫调节中的差异作用。
Immunity. 2015 Oct 20;43(4):739-50. doi: 10.1016/j.immuni.2015.08.019. Epub 2015 Sep 29.
3
Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability.不依赖白细胞介素-23的白细胞介素-17产生调节肠道上皮通透性。
Immunity. 2015 Oct 20;43(4):727-38. doi: 10.1016/j.immuni.2015.09.003. Epub 2015 Sep 29.
4
Dietary Non-digestible Polysaccharides Ameliorate Intestinal Epithelial Barrier Dysfunction in IL-10 Knockout Mice.膳食不可消化多糖改善白细胞介素-10基因敲除小鼠的肠道上皮屏障功能障碍
J Crohns Colitis. 2016 Sep;10(9):1076-86. doi: 10.1093/ecco-jcc/jjw065. Epub 2016 Mar 3.
5
Regulation of gut inflammation and th17 cell response by interleukin-21.白细胞介素-21对肠道炎症和Th17细胞反应的调节
Gastroenterology. 2008 Apr;134(4):1038-48. doi: 10.1053/j.gastro.2008.01.041. Epub 2008 Jan 17.
6
Neutralizing IL-23 is superior to blocking IL-17 in suppressing intestinal inflammation in a spontaneous murine colitis model.在自发性小鼠结肠炎模型中，中和白细胞介素-23在抑制肠道炎症方面优于阻断白细胞介素-17。
Inflamm Bowel Dis. 2015 May;21(5):973-84. doi: 10.1097/MIB.0000000000000353.
7
Role of cytokines in the early stages of chronic colitis in TCR alpha-mutant mice.细胞因子在TCRα突变小鼠慢性结肠炎早期阶段的作用。
Lab Invest. 1997 Mar;76(3):385-97.
8
IL-7 exacerbates chronic colitis with expansion of memory IL-7Rhigh CD4+ mucosal T cells in mice.白细胞介素-7通过扩增小鼠记忆性白细胞介素-7受体高表达的CD4⁺黏膜T细胞加剧慢性结肠炎。
Am J Physiol Gastrointest Liver Physiol. 2005 Apr;288(4):G745-54. doi: 10.1152/ajpgi.00276.2004. Epub 2004 Nov 18.
9
Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice.在小鼠急性结肠炎中，IL-1α 和 IL-1β 的非冗余特性。
Gut. 2014 Apr;63(4):598-609. doi: 10.1136/gutjnl-2012-303329. Epub 2013 Jun 21.
10
IL-17 is a protection effector against the adherent-invasive Escherichia coli in murine colitis.白细胞介素-17是小鼠结肠炎中针对黏附侵袭性大肠杆菌的一种保护性效应因子。
Mol Immunol. 2018 Jan;93:166-172. doi: 10.1016/j.molimm.2017.11.020. Epub 2017 Nov 28.
引用本文的文献
1
Adverse Events and Immune Response in Psoriasis Patients Receiving Interleukin-17 Inhibitors.接受白细胞介素-17抑制剂治疗的银屑病患者的不良事件和免疫反应
Acta Derm Venereol. 2025 Aug 18;105:adv43685. doi: 10.2340/actadv.v105.43685.
2
Restorative Effects of Synbiotics on Colonic Ultrastructure and Oxidative Stress in Dogs with Chronic Enteropathy.合生元对慢性肠病犬结肠超微结构和氧化应激的修复作用。
Antioxidants (Basel). 2025 Jun 13;14(6):727. doi: 10.3390/antiox14060727.
3
IL-17A antagonist biosimilar-induced ulcerative colitis in a patient with ankylosing spondylitis.一名强直性脊柱炎患者使用白细胞介素-17A拮抗剂生物类似药后诱发溃疡性结肠炎。
Arch Med Sci. 2025 Feb 28;21(1):339-340. doi: 10.5114/aoms/200477. eCollection 2025.
4
Redirecting immune signaling with cytokine adaptors.利用细胞因子衔接蛋白重定向免疫信号传导。
Nat Commun. 2025 Mar 11;16(1):2432. doi: 10.1038/s41467-025-57681-1.
5
The role of interleukin-17 in inflammation-related cancers.白细胞介素-17在炎症相关癌症中的作用。
Front Immunol. 2025 Jan 21;15:1479505. doi: 10.3389/fimmu.2024.1479505. eCollection 2024.
6
Clinical features, treatment, and prognosis of secukinumab-induced inflammatory bowel disease.司库奇尤单抗诱导的炎症性肠病的临床特征、治疗及预后
Eur J Med Res. 2025 Jan 19;30(1):37. doi: 10.1186/s40001-025-02295-y.
7
Granzyme K mediates IL-23-dependent inflammation and keratinocyte proliferation in psoriasis.颗粒酶 K 介导银屑病中 IL-23 依赖性炎症和角质形成细胞增殖。
Front Immunol. 2024 Jun 5;15:1398120. doi: 10.3389/fimmu.2024.1398120. eCollection 2024.
8
The IL-17 family in diseases: from bench to bedside.IL-17 家族与疾病：从基础到临床。
Signal Transduct Target Ther. 2023 Oct 11;8(1):402. doi: 10.1038/s41392-023-01620-3.
9
New onset severe ulcerative colitis following Ixekizumab therapy.使用司库奇尤单抗治疗后新发的重度溃疡性结肠炎。
Arch Clin Cases. 2022 Dec 19;9(4):173-176. doi: 10.22551/2022.37.0904.10227. eCollection 2022.
10
Lactococcus lactis engineered to deliver hCAP18 cDNA alleviates DNBS-induced colitis in C57BL/6 mice by promoting IL17A and IL10 cytokine expression.经工程改造的乳球菌乳亚种递送 hCAP18 cDNA 通过促进 IL17A 和 IL10 细胞因子表达缓解 C57BL/6 小鼠的 DNBS 诱导的结肠炎。
Sci Rep. 2022 Sep 19;12(1):15641. doi: 10.1038/s41598-022-19455-3.
本文引用的文献
1
Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability.不依赖白细胞介素-23的白细胞介素-17产生调节肠道上皮通透性。
Immunity. 2015 Oct 20;43(4):727-38. doi: 10.1016/j.immuni.2015.09.003. Epub 2015 Sep 29.
2
Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation.白细胞介素-23 和白细胞介素-17 在肠道免疫调节中的差异作用。
Immunity. 2015 Oct 20;43(4):739-50. doi: 10.1016/j.immuni.2015.08.019. Epub 2015 Sep 29.
3
Growth Factor FGF2 Cooperates with Interleukin-17 to Repair Intestinal Epithelial Damage.生长因子 FGF2 与白细胞介素-17 合作修复肠道上皮损伤。
Immunity. 2015 Sep 15;43(3):488-501. doi: 10.1016/j.immuni.2015.06.024. Epub 2015 Aug 25.
4
Secukinumab: first global approval.司库奇尤单抗：全球首次获批。
Drugs. 2015 Feb;75(3):329-38. doi: 10.1007/s40265-015-0359-0.
5
Cutting edge: regulation of intestinal inflammation and barrier function by IL-17C.前沿：IL-17C 对肠道炎症和屏障功能的调节作用。
J Immunol. 2012 Nov 1;189(9):4226-30. doi: 10.4049/jimmunol.1103014. Epub 2012 Sep 28.
6
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.司库奇尤单抗，一种人源抗白细胞介素-17A 单克隆抗体，用于中重度克罗恩病：一项随机、双盲、安慰剂对照试验的意外结果。
Gut. 2012 Dec;61(12):1693-700. doi: 10.1136/gutjnl-2011-301668. Epub 2012 May 17.
7
The effects of Th17 cytokines on the inflammatory mediator production and barrier function of ARPE-19 cells.Th17 细胞因子对 ARPE-19 细胞炎症介质产生和屏障功能的影响。
PLoS One. 2011 Mar 30;6(3):e18139. doi: 10.1371/journal.pone.0018139.
8
A protective function for interleukin 17A in T cell-mediated intestinal inflammation.白细胞介素17A在T细胞介导的肠道炎症中的保护作用。
Nat Immunol. 2009 Jun;10(6):603-9. doi: 10.1038/ni.1736.
9
TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.转化生长因子-β和白细胞介素-6驱动T细胞产生白细胞介素-17和白细胞介素-10，并抑制辅助性T细胞17介导的病理过程。
Nat Immunol. 2007 Dec;8(12):1390-7. doi: 10.1038/ni1539. Epub 2007 Nov 11.
10
IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.白细胞介素-23对T细胞介导的结肠炎至关重要，并通过白细胞介素-17和白细胞介素-6促进炎症反应。
J Clin Invest. 2006 May;116(5):1310-6. doi: 10.1172/JCI21404.
Zotero 插件